Skip to content

Sarah Nemec, Senior VP, Finance and PAO at Bolt Biotherapeutics, bought BOLT on Jun 5, 2026

Data as of Oct 16

▲ BUY$2K509 shares at $3.88Sarah Nemec Senior VP, Finance and PAOBOLT Bolt Biotherapeutics, Inc.
Watch BOLT
Traded
Jun 5, 2026
Disclosed
Sep 21, 2026
Filed
108 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Sarah Nemec, Senior VP, Finance and PAO at Bolt Biotherapeutics, bought BOLT on Jun 5, 2026TRADEDDISCLOSED
BOLTSimilar stocks (XLV — its sector index fund), rebased to BOLT's price on the disclosure day
BOLT since disclosure
+11.4%
Similar stocks (XLV) since disclosure
+4.6%
XLV — its sector index fund

Change in closing price from Sep 21, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSarah Nemec Senior VP, Finance and PAOBOLT Bolt Biotherapeutics, Inc.$13.2Kdisclosed Sep 21 · filed 3 days after the trade
  2. ▼ SELLSarah Nemec Senior VP, Finance and PAOBOLT Bolt Biotherapeutics, Inc.$9.7Kdisclosed Sep 21 · filed 4 days after the trade
  3. ▼ SELLSarah Nemec Senior VP, Finance and PAOBOLT Bolt Biotherapeutics, Inc.$3.2Kdisclosed Sep 21 · filed 5 days after the trade · late

See every trade on BOLT →